(NASH), a more serious condition associated with inflammation in and damage to the hepatocytes, which is generally accompanied by liver fibrosis. NASH can also progress to cirrhosis and hepatocellular carcinoma [2]. The prevalence of NASH is expected to increase to 56% over the next 10 years ...
Nonalcoholic fatty liver disease (NAFLD) directly affects 10–30% of the human population and is characterized by pathological alterations ranging from simple steatosis to nonalcoholic steatohepatitis (NASH), fibrosis, and irreversible cirrhosis. NAFLD is considered a hepatic component of metabolic ...